2010Zhongguo linchuang shiyong yixueRequires access

Comparative study between escitalopram and paroxetine in the treatment of depression

Jian-hui Hao, Yahui Guo

Open publisher page 0 citations

Abstract

Objective To observe the clinical efficacy and safety of escitalporam in the treatment of depression. Methods 68 patients with depression randomly devided into escitalopram group and paroxetine group for 6 weeks. clinical efficacy was evaluated using Hamilton depression scale(HAMD) and Hamilton anxiety scale (HAMA) and treatment emergent symptoms scales(TESS)were used to evaluate the advense effects. Results The effective rate of escitalopram was94. 1% and paroxetine group was91.1%. Escitalopram group showed a highter response rate compared with paroxetine group after one week treatment. Conclusion Escitalopram is an effective and safe drug in the treatment of depression. Key words: Escitalopram;  Paroxetine;  Depression

About this research paper

What this paper is about

Objective To observe the clinical efficacy and safety of escitalporam in the treatment of depression. Methods 68 patients with depression randomly devided into escitalopram group and paroxetine group for 6 weeks. clinical efficacy was evaluated using Hamilton depression scale(HAMD) and Hamilton anxiety scale (HAMA) and treatment emergent symptoms scales(TESS)were used to evaluate the advense effects. Results The effective rate of escitalopram was94. 1% and paroxetine group was91.1%. Escitalopram group showed a highter response rate compared with paroxetine group after one week treatment. Conclusion Escitalopram is an effective and safe drug in the treatment of depression. Key words: Escitalopram;  Paroxetine;  Depression

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical efficacy and safety of escitalporam in the treatment of depression. Methods 68 patients with depression randomly devided into escitalopram group and paroxetine group for 6 weeks. clinical efficacy was evaluated using Hamilton depression scale(HAMD) and Hamilton anxiety scale (HAMA) and treatment emergent symptoms scales(TESS)were used to evaluate the advense effects. Results The effective rate of escitalopram was94. 1% and paroxetine group was91.1%. Escitalopram group showed a highter response rate compared with paroxetine group after one week treatment. Conclusion Escitalopram is an effective and safe drug in the treatment of depression. Key words: Escitalopram;  Paroxetine;  Depression

Key concepts: Escitalopram, Paroxetine, Hamd, Depression (economics), Hamilton depression scale, Psychology, Psychiatry, Clinical efficacy

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparative study between escitalopram and paroxetine in the treatment of depression — Research Paper | ScholarLens